²é¿´: 504  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴

hwoda

½ð³æ (ÕýʽдÊÖ)

½ÌÊé½³

[ÇóÖú] ÇóÖú²éһƪÂÛÎÄÊÇ·ñ±»SCI¼ìË÷-2014.9.4

×÷Õß:
S Zhou
ÎÄÌâ:
Theoretical Studies on Binding and Specificity Mechanisms of Farnesyltransferase (FTase) and Geranylgeranyltransferase Type-I (GGTase-I) Inhibitors by Molecular Modeling.
ÆÚ¿¯Ãû:
Combinatorial Chemistry & High Throughput Screening
ÆÚ¿¯Äê·Ý:
2014
¾í(ÆÚ),ÆðÖ¹Ò³Âë:
17(6):509-519
È«ÎÄÁ´½Ó:
http://europepmc.org/abstract/med/24444014
Êý¾Ý¿âÃû³Æ:
Bentham Science Publishers
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ËæÔµ£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hwoda: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл£¡ 2014-09-04 23:19:50
2Â¥2014-09-04 22:58:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

oven1986: LS-EPI+1, ¸ÐлӦÖú£¡ 2014-09-05 09:44:59
Theoretical Studies on Binding and Specificity Mechanisms of Farnesyltransferase (FTase) and Geranylgeranyltransferase Type-I (GGTase-I) Inhibitors by Molecular Modeling


×÷Õß:Zhou, SR (Zhou, Shirou)




COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING



¾í: 17

ÆÚ: 6

Ò³: 509-519

DOI: 10.2174/1386207317666140120122920

³ö°æÄê: 2014

²é¿´ÆÚ¿¯ÐÅÏ¢












































ÕªÒª

Farnesyltransferase (FTase) and geranylgeranyltransferase type-I (GGTase-I) are two members of protein prenyltransferases, which play critical roles in lipid post-translational modifications. Potent inhibitors of FTase and GGTase-I have been confirmed to show favorable influence on the therapies of various diseases, such as cancers, malaria and Toxoplasmosis. However, designing highly specific inhibitors toward FTase or GGTase-I without influencing their binding affinity remains a big challenge. In this work, molecular docking, molecular dynamics (MD) simulations and MM/GBSA free energy calculations were employed to study the bindings of two highly selective inhibitors (lonafarnib and GGTI-2133) towards FTase or GGTase-I. The specificities of the studied inhibitors derived from the predicted binding free energies are consistent with the experimental data. The analysis of the energetic components illustrates that both the non-polar and polar interactions play critical roles in determining the specificity between FTase and GGTase-I. Moreover, the protein-inhibitor interaction spectra for the studied inhibitors were determined through the decomposition of the binding free energies, and the important residues for binding and specificity were highlighted. Our study provides useful information for the rational design of selective FTase or GGTase-I inhibitors.


¹Ø¼ü´Ê

×÷Õ߹ؼü´Ê:Free energy decomposition; FTase; GGTase-I; MM/GBSA; molecular docking; molecular dynamics simulations; Prenyltransferase; specificity

KeyWords Plus:FREE-ENERGY CALCULATIONS; PEPTIDE INTERACTION INTERFACE; CHRONIC MYELOID-LEUKEMIA; INDUCED LUNG-CANCER; PROTEIN FARNESYLTRANSFERASE; DRUG-RESISTANCE; FORCE-FIELD; HETEROLOGOUS EXPRESSION; DYNAMICS SIMULATIONS; TRYPANOSOMA-BRUCEI


×÷ÕßÐÅÏ¢

ͨѶ×÷ÕßµØÖ·: Zhou, SR (ͨѶ×÷Õß)



      

Yueyang Vocat Tech Coll, Dept Basic Med, Yueyang 414000, Hunan, Peoples R China.



µØÖ·:



      

[ 1 ] Yueyang Vocat Tech Coll, Dept Basic Med, Yueyang 414000, Hunan, Peoples R China



µç×ÓÓʼþµØÖ·:shirouzhou@126.com


³ö°æÉÌ

BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES


Àà±ð / ·ÖÀà

Ñо¿·½Ïò:Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy

Web of Science Àà±ð:Biochemical Research Methods; Chemistry, Applied; Pharmacology & Pharmacy


ÎÄÏ×ÐÅÏ¢

ÎÄÏ×ÀàÐÍ:Article

ÓïÖÖ:English

Èë²ØºÅ: WOS:000338848600004

ISSN: 1386-2073

µç×Ó ISSN: 1875-5402


ÆÚ¿¯ÐÅÏ¢


Impact Factor (Ó°ÏìÒò×Ó): Journal Citation Reports®


ÆäËûÐÅÏ¢

IDS ºÅ: AL0WU

Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 71

Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 0
3Â¥2014-09-04 22:58:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ hwoda µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 07»¯Ñ§280·ÖÇóµ÷¼Á +4 722865 2026-03-23 4/200 2026-03-24 00:01 by chixmc
[¿¼ÑÐ] Ò»Ö¾Ô¸¹ú¿Æ¹ý³ÌËù081700£¬274Çóµ÷¼Á +3 ÈýË®ÑÐ0Ë®Á¢·½ 2026-03-23 3/150 2026-03-23 23:11 by MajorWen
[¿¼ÑÐ] 333Çóµ÷¼Á +3 ALULU4408 2026-03-23 3/150 2026-03-23 19:04 by macy2011
[¿¼ÑÐ] 291 Çóµ÷¼Á +4 »¯¹¤2026½ì±ÏÒµÉ 2026-03-21 5/250 2026-03-23 16:46 by »¯¹¤2026½ì±ÏÒµÉ
[¿¼ÑÐ] 08¹¤Ñ§µ÷¼Á +7 Óû§573181 2026-03-20 11/550 2026-03-23 15:47 by ÎÒ°®Ñ§Ï°Ñ§Ï°Ê¹Î
[¿¼ÑÐ] 263Çóµ÷¼Á +6 yqdszhdap£­ 2026-03-22 9/450 2026-03-23 12:57 by yqdszhdap£­
[¿¼ÑÐ] 352Çóµ÷¼Á +3 ´óÃ×·¹£¡ 2026-03-22 3/150 2026-03-22 23:28 by king123£¡
[¿¼ÑÐ] 317Çóµ÷¼Á +12 Éê×ÓÉêÉê 2026-03-19 18/900 2026-03-22 22:23 by luoyongfeng
[¿¼ÑÐ] Çóµ÷¼Á +7 Auroracx 2026-03-22 7/350 2026-03-22 12:38 by ËØÑÕÇã³Ç1988
[¿¼ÑÐ] ³õÊÔ 317 +7 °ëÀ­Ô±û 2026-03-20 7/350 2026-03-21 22:26 by peike
[¿¼ÑÐ] 311Çóµ÷¼Á +3 Ó¸ҵÄСÎâ 2026-03-20 3/150 2026-03-21 17:40 by ColorlessPI
[¿¼ÑÐ] ²ÄÁÏѧѧ˶080502 337Çóµ÷¼Á-Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ +4 ˳˳˳mr 2026-03-18 5/250 2026-03-21 10:22 by luoyongfeng
[¿¼ÑÐ] 301Çóµ÷¼Á +10 yyÒªÉϰ¶Ñ½ 2026-03-17 10/500 2026-03-21 03:14 by JourneyLucky
[¿¼ÑÐ] »ª¶«Ê¦·¶´óѧ-071000ÉúÎïѧ-293·Ö-Çóµ÷¼Á +3 Ñо¿ÉúºÎÑþÃ÷ 2026-03-18 3/150 2026-03-21 01:30 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬Çóµ÷¼Á +5 ²Ä»¯ÖðÃÎÈË 2026-03-18 5/250 2026-03-21 00:26 by JourneyLucky
[¿¼ÑÐ] 330Çóµ÷¼Á +4 С²Ä»¯±¾¿Æ 2026-03-18 4/200 2026-03-20 23:13 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏѧ˶297ÒѹýËÄÁù¼¶Çóµ÷¼ÁÍÆ¼ö +11 adaie 2026-03-19 11/550 2026-03-20 21:30 by laoshidan
[¿¼ÑÐ] ²ÄÁÏѧ˶318Çóµ÷¼Á +5 February_Feb 2026-03-19 5/250 2026-03-19 23:51 by 23Postgrad
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +4 18889395102 2026-03-18 4/200 2026-03-19 16:13 by 30660438
[¿¼ÑÐ] ²ÄÁÏ£¬·ÄÖ¯£¬ÉúÎ0856¡¢0710£©£¬»¯Ñ§ÕÐÉúÀ² +3 Eember. 2026-03-17 9/450 2026-03-18 10:28 by Eember.
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û